ARCHIVES

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012

Roswell Park Wins Grants For Young Investigators.

January 11, 2002

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005

2015 Breakthrough Prize Winners Announced at Gala

November 14, 2014

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014